Metraipolis › archive › dc_f1844f42c4fa
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators — Europe PMC PMID:41154689
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41154689
- DOI
- 10.3390/biom15101460
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:39:38.856Z
- SHA-256 of the archived text
ac7623b0f83646a2d2fb77212806c50aee7d58f1a8fb953c3f546d1ec0ece530- Stable URL of this page
https://metraipolis.com/documento/dc_f1844f42c4fa
How to cite
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators — Europe PMC PMID:41154689 — Europe PMC (en), https://europepmc.org/article/MED/41154689 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1844f42c4fa (Metraipolis archive dc_f1844f42c4fa, sha256 ac7623b0f83646a2d2fb77212806c50aee7d58f1a8fb953c3f546d1ec0ece530)
BibTeX
@misc{dcf1844f42c4fa,
title = {Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators — Europe PMC PMID:41154689},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41154689},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1844f42c4fa; sha256 ac7623b0f83646a2d2fb77212806c50aee7d58f1a8fb953c3f546d1ec0ece530},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154689. Agents can read the archived copy with the MCP tool read_document.